Press Release | Thu Sep 13, 2012 7:00am EDT

Medivation and Astellas Announce XTANDI(R) (Enzalutamide) Is Now Available for Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

* Reuters is not responsible for the content in this press release.